💊 Stipple Bio, a cancer biotech, raised a $100m Series A. RA Capital, a16z Bio+Health and Nextech Invest led, joined by Emerson Collective Investments, GV, LoLa Capital Partners and GordonMD Global Investments. Go deeper
• Beacon Biosignals, a Boston-based brain data startup, raised an $11m extension to its Series B round. Investors included JSL Health, Palo Santo VC, Kicker Ventures, and Samsung Next. Go deeper
